HYLAFEM BORICUM ACIDUM 3X
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- HYLAFEM BORICUM ACIDUM 3X
- Generic name
- BORICUM ACIDUM
- Manufacturer
- U.S. PHARMACEUTICAL CORPORATION
- Product type
- HUMAN OTC DRUG
- SPL set ID
- fcd50c95-2522-418f-a2f3-de7e22622363
- SPL ID
- 108fa2fe-f7a1-4c68-927e-70ef523e81d0
- Version
- 5
- Effective date
- 2022-11-17
- Source export date
- 2026-10-12
- Source partition
- 1
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/7928c8e8c6256620071a8b7e5b93eb8dfa543649c08d17a01ea02251012ba58c/drug-label-0001-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:26:33
| Harmonized routes |
|---|
| VAGINAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | HYLAFEM BORICUM ACIDUM 3X | openfda.brand_name | |
| generic name | BORICUM ACIDUM | openfda.generic_name | |
| manufacturer name | U.S. PHARMACEUTICAL CORPORATION | openfda.manufacturer_name | |
| ndc | package | 52747-255-03 | openfda.package_ndc |
| ndc | product | 52747-255 | openfda.product_ndc |
| ndc11 | package | 52747025503 | derived:openfda.package_ndc |
| spl id | 108fa2fe-f7a1-4c68-927e-70ef523e81d0 | id | |
| spl set id | fcd50c95-2522-418f-a2f3-de7e22622363 | set_id | |
| unii | R57ZHV85D4 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings For vaginal use only Do not use if you have never had a vaginal yeast infection diagnosed by a doctor.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Adverse reactions and side effects The adverse effects are considered mild and may include watery discharge, erythema, or slight burning sensation. You should contact your healthcare provider for medical advice about adverse events or report a serious adverse event, by contacting US Pharmaceutical Corporation at the address listed below. Distributed by: US Pharmaceutical Corporation 2443 Park Central Blvd Decatur, GA 30035, USA
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.